https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020405s007lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/019071s012lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_050803.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21437lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/009330s034lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214154s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_022502.pdf
https://www.fda.gov/files/drugs/published/FDA%20EPC%20Text%20Phrases%20for%20Indications%20and%20Usage%20heading%20in%20Highlights%20%28updated%20June%202019%29.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/012616Orig1s078ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021316s036lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021098s017lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_021946.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021283s053lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/20838s024lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/019123s027lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/209803%2C209805%2C209806Orig1s000MedR.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/19915se5-037_monopril_lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202611orig1s000medr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021648s004lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022028s000_Lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20386s28lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21437se1-002_inspra_lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020136s014lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/009330s033lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018279s034lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019777s054lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021873s000_Lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020838s022lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/209478Orig1s000NameR.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021366s021lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-290_Tracleer_medr_P2.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021676s009lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/20-387S010_Hyzaar.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/18-200S024_Midamor_Prntlbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021873lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021098s005lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/21098lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020838s031lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/19982_Zebeta_Corres_P2.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-437_Inspra_Pharmr_P3.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018225s024lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022574s004lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021437s006lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/022225Orig1s000PharmR.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-098_Yasmin_admincorres_P1.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/012151s062ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021283Orig1s037,020818Orig1s054ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020665Orig1s038ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/019885Orig1s041ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021283Orig1s046ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018998s076lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021742s000_ClinPharmR_P1.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021676s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022028lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-098_Yasmin_medr_P1.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-098_Yasmin_pharmr_P1.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/076110.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/012151s062lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012151s075lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/012151s072lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/012616s075lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209478s003lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/Spironolactone_tabs_12151_RC12-09.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/012616s068lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/HCTZ_Spironolactone_tabs_12616_RC12-09.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/Spironolactone%20Suspension%20Oral%20NDA%20209478%20RC%2009-2018.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/012616s073lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/012151Orig1s077ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/209478Orig1s000MedR.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/209478Orig1s002ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/209478Orig1s003ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/209478Orig1s000ClinPharmR.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/012616Orig1s080ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/012151Orig1s068ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/anda/2001/40-424_Spironolactone_Prntlbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/209478Orig1s000OtherR.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-437S002_Inspra_Medr_P1.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/209478Orig1s000ChemR.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/anda/2001/40-424_Spironolactone_Admindocs.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/209478Orig1s000SumR.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-437_Inspra_Medr_P2.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/012151Orig1s071ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/anda/2001/40-424_Spironolactone_Approv.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/anda/2001/40-424_Spironolactone_Chemr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-437S002_Inspra_Medr_P4.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/209478Orig1s000Approv.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/anda/2001/40-424_Spironolactone_Bioeqr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/012616Orig1s073ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/anda/2001/40-424_Spironolactone_Corres.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/012151s067ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/012616Orig1s075ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-437_Inspra_BioPharmr_P3.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-098_Yasmin_admincorres_P9.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-437S002_Inspra_Medr_P2.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-437_Inspra_Medr_P5.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/012616s069ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-437_Inspra_Medr_P6.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/012616s068ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212801s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-437_Inspra_Medr_P3.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022028s005lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019129s056lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019885s039lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020838s041lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-437_Inspra_Medr_P8.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019071s013lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_019931.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/20859_Sonata_medr_P3.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/209478Orig1s000ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-437_Inspra_Pharmr_P2.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207078s007lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-437_Inspra_Medr_P1.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/97/20788_PROPECIA%20TABLETS,%201MG_MEDR_P1.PDF
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/017378s068,017385s059lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/FAERS%20ICRS%20CQ%20HCQ%20(specified)%203588.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021366s037lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207620s013lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/Benzoyl_Peroxide_Erythromycin_Topical_Gel_5_3_50769_RV_Nov_2018.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/207620Orig1s018.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020184s015ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-437_Inspra_Pharmr_P1.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020386s060lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_209353.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_202428.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/Benzoyl_Clindamycin_Gel_25_12_NDA_050819_RV_Nov_2018.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_211527.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021648s005lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021676s000_MEDR_pt1.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_017340.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/211964Orig1s000OtherR.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_212379.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213218s001lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_050769.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_050782.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/Tretinoin_Topical%20gel_NDA%20017955_RV%20Nov%202018.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_020475-Gel-0.04P.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2001/40424ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/213433Orig1s000MultidisciplineR.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2022/214012Orig1s000MedR.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208019s002lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020136s023lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_020475.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-437_Inspra_Medr_P4.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021648Orig1s008ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/Tazarotene%20Cream%200.1_NDA%20021184%20RV%20Feb%202019.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_211882.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020136s027lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_020475-Gel-0.1P.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/Clindamycin%20Phosphate_Topical%20lotion_NDA%20050600_RV%20Nov%202018.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213218s000lbl.pdf
https://www.accessdata.fda.gov/cdrh_docs/pdf/K963080.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/Clindamycin%20Phosphate_Topical%20gel_NDA%2050782%20RV%20Nov%202018.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_213433.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/211964Orig1s000IntegratedR.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_207154.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/207620Orig1s000OtherR.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/Sulfacetamide%20Sodium_Topical%20lotion%20or%20Suspension_NDA%2019931%20RV%20Nov%202018.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/207620Orig1s000ClinPharmR.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_050741.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/213433Orig1s000RiskR.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/009330Orig1s036lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-098_Yasmin_prntlbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/215341Orig1s000IntegratedR.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/Dapsone_Topical%20gel_NDA%20207154_RV%20Nov%202018.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/212379Orig1s000MultidisciplineR.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020405Orig1s011ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019982s016lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/012616Orig1s074ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021437s013lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021098s019lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/Tretinoin_Topical%20gel%200.1_NDA%20020475_RV%20Nov%202018.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/Tretinoin_Topical%20gel_NDA%20017579_RV%20Nov%202018.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/202379Orig1s021ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/Tretinoin_Topical%20cream_NDA%20017340_RV%20Nov%202018.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-290_Tracleer_medr_P3.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/021648s000_PRNTLBL.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/Azelaic%20Acid%20Cream%2020%20NDA%20020428%20PSG%20Page%20RV%20May%202019.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_021184-Cre-0.1P.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022310s000_MedR.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020838s033lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_016921.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/009330Orig1s030ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/1999/40353ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-272_Remodulin_biopharmr_P2.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019558s061lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_020600-Gel-0.1P.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020591s030lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/209478Orig1s000PharmR.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/012151Orig1s075ltr.pdf
https://www.accessdata.fda.gov/cdrh_docs/reviews/K193397.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018716s026lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020136ap_s08_s09.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/210874Orig1s000MedR.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019834s025lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208019s003lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021676s012lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020405s013lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211367s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020405s015lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/016679s108lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/Adapalene_Topical%20cream_NDA%20020748_RV%20Nov%202018.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202107Orig1s000Lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021648s006lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205739s016lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020838s035lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/207078s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/Adapalene_Benzoyl_Peroxide_Gel_0.1_2.5_NDA_22320_RV_Nov_2018.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/019439s022lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207078s008lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202107Orig1s000MedR.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022532s009lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020552s007lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020498s028lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020838s026lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022532s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_017955.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019778s047lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020528s023lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021648s011lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/021355s000_MedR_Part2.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020702s056lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020702Orig1s060lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_050600.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_207917.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/216285s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022532s004lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-098_Yasmin_medr_P3.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205739s037lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020405s005lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022310lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207620orig1s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/022341Orig1s027.pdf